康乃德生物制药

CNTB

全部股东

股东类型

  • 风投/私募28.70%
  • 机构投资者23.68%
  • 个人与内部人士15.19%
  • 对冲基金13.34%
  • 其他19.09%

主要股东

主要股东 最新
股东
Panacea Venture Management Co., Ltd.
21.14%1,331.00 万0.15%+15.00 万
Wubin PanCo-Founder & Former Director
9.57%602.68 万0.04%+0
Suzhou Xiangtang Venture Investment Limited
7.61%478.98 万0.03%+0
Advantech Capital Advisors II Limited
7.56%476.22 万0.03%+0
Ikarian Capital, LLC
7.21%453.85 万1.39%-85.00 万
BML Capital Management, LLC
6.14%386.44 万5.23%+329.11 万
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
4.38%275.65 万3.31%-208.44 万
Zheng WeiCo-Founder & Former Director
4.00%252.04 万2.18%-135.57 万
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
3.85%242.46 万0.02%+0
683 Capital Management, LLC
2.04%128.50 万0.61%+38.50 万
Boothbay Fund Management, LLC
1.55%97.37 万0.42%-26.09 万
LAV Investment Adviser Limited
1.45%91.23 万<0.01%+0
BlackRock, Inc.
1.38%87.17 万--+87.17 万
Perceptive Advisors LLC
1.26%79.27 万<0.01%+0
ADAR1 Capital Management, LLC
1.11%70.00 万0.07%-4.24 万
Silverarc Capital Management, LLC
0.87%54.50 万--+54.50 万
Richmond Brothers, Inc.
0.85%53.56 万0.09%+5.90 万
Knott Partners Management, LLC
0.71%44.49 万0.09%+5.70 万
Braden Leonard
0.64%40.00 万--+40.00 万
Stonepine Capital Management LLC
0.58%36.43 万0.08%+5.43 万